tetraphenylphosphonium has been researched along with glutamic acid in 13 studies
| Studies (tetraphenylphosphonium) | Trials (tetraphenylphosphonium) | Recent Studies (post-2010) (tetraphenylphosphonium) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
|---|---|---|---|---|---|
| 438 | 0 | 39 | 41,757 | 452 | 12,876 |
| Protein | Taxonomy | tetraphenylphosphonium (IC50) | glutamic acid (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
| Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimmich, GA; Wingrove, TG | 1 |
| Koch, CD; LaNoue, KF; Strzelecka, D; Strzelecki, T | 1 |
| Harris, RA; Stokes, JA | 1 |
| Daval, JL; Koziel, V; Nicolas, F; Oillet, J | 1 |
| Ferreira, FM; Palmeira, CM; Santos, MS; Seiça, R | 1 |
| Brustovetsky, N; Dubinsky, JM | 2 |
| Muth, TR; Schuldiner, S | 1 |
| Mordoch, SS; Schuldiner, S; Yerushalmi, H | 1 |
| Adler, J; Bibi, E; Lewinson, O | 1 |
| Faull, KF; Kaback, HR; Schuldiner, S; Soskine, M; Vazquez-Ibar, JL; Weinglass, AB; Whitelegge, JP | 1 |
| Schuldiner, S; Sharoni, M; Steiner-Mordoch, S | 1 |
| Henzler-Wildman, KA; Morrison, EA; Robinson, AE; Thomas, NE; Werner, JP; Wu, C | 1 |
13 other study(ies) available for tetraphenylphosphonium and glutamic acid
| Article | Year |
|---|---|
The characterization of intestinal acidic amino-acid transport.
Topics: Animals; Aspartic Acid; Binding, Competitive; Biological Transport, Active; Chickens; Diflunisal; Electrochemistry; Glutamates; Glutamic Acid; Indicators and Reagents; Intestinal Mucosa; Membrane Potentials; Methylglucosides; Onium Compounds; Organophosphorus Compounds; Potassium; Sodium | 1985 |
Sites of action of glucagon and other Ca2+ mobilizing hormones on the malate aspartate cycle.
Topics: Animals; Aspartic Acid; Binding Sites; Calcium; Glucagon; Glutamates; Glutamic Acid; Intracellular Membranes; Ketoglutaric Acids; Malates; Mitochondria, Liver; Onium Compounds; Organophosphorus Compounds; Oxidation-Reduction; Rats; Rats, Inbred Strains | 1988 |
Effects of a sedative and a convulsant barbiturate on synaptosomal calcium transport.
Topics: Animals; Barbiturates; Biological Transport; Brain; Calcium; Convulsants; Glutamates; Glutamic Acid; Hypnotics and Sedatives; Male; Mice; Mice, Inbred BALB C; Onium Compounds; Organophosphorus Compounds; Pentobarbital; Synaptosomes | 1982 |
Analysis of glutamate receptors in primary cultured neurons from fetal rat forebrain.
Topics: Animals; Animals, Newborn; Binding, Competitive; Cell Membrane; Cells, Cultured; Embryo, Mammalian; Female; Fetus; Glutamic Acid; Kinetics; N-Methylaspartate; Neurons; Onium Compounds; Organophosphorus Compounds; Potassium; Pregnancy; Prosencephalon; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Tritium | 1995 |
Alterations of liver mitochondrial bioenergetics in diabetic Goto-Kakizaki rats.
Topics: Adenine Nucleotides; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Respiration; Diabetes Mellitus; Energy Metabolism; Glutamic Acid; Malates; Male; Membrane Potentials; Mitochondria, Liver; Onium Compounds; Organophosphorus Compounds; Oxygen Consumption; Phosphorylation; Rats; Succinic Acid | 1999 |
Dual responses of CNS mitochondria to elevated calcium.
Topics: Adenosine Diphosphate; Animals; Antineoplastic Agents; Atractyloside; Brain; Calcium; Electric Conductivity; Fluorescent Dyes; Fura-2; Glutamic Acid; Membrane Potentials; Mitochondria; Mitochondrial Swelling; Nerve Degeneration; Oligomycins; Onium Compounds; Organophosphorus Compounds; Oxidation-Reduction; Oxygen Consumption; Rats; Strontium; Succinic Acid; Uncoupling Agents | 2000 |
A membrane-embedded glutamate is required for ligand binding to the multidrug transporter EmrE.
Topics: Amino Acid Sequence; Antiporters; Aspartic Acid; Bacterial Proteins; Binding Sites; Biological Transport; Carrier Proteins; Cell Membrane; Conserved Sequence; Escherichia coli; Escherichia coli Proteins; Glutamic Acid; Hydrogen-Ion Concentration; Indicators and Reagents; Kinetics; Membrane Proteins; Molecular Sequence Data; Onium Compounds; Organophosphorus Compounds; Recombinant Proteins | 2000 |
Limitations of cyclosporin A inhibition of the permeability transition in CNS mitochondria.
Topics: Adenosine Diphosphate; Animals; Brain; Brain Chemistry; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cyclophilins; Cyclosporine; Enzyme Inhibitors; Glutamic Acid; Intracellular Membranes; Magnesium; Membrane Potentials; Mitochondria; Mitochondrial Swelling; Oligomycins; Onium Compounds; Organophosphorus Compounds; Palmitic Acid; Permeability; Polyethylene Glycols; Rats; Serum Albumin, Bovine | 2000 |
A single carboxyl mutant of the multidrug transporter EmrE is fully functional.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antiporters; Binding Sites; Dicyclohexylcarbodiimide; Escherichia coli; Escherichia coli Proteins; Glutamic Acid; Hydrogen-Ion Concentration; Kinetics; Liposomes; Membrane Proteins; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Onium Compounds; Organophosphorus Compounds; Paraquat; Protein Structure, Secondary; Proteolipids; Recombinant Proteins | 2001 |
Role of a conserved membrane-embedded acidic residue in the multidrug transporter MdfA.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin Resistance; Benzalkonium Compounds; Cations; Cell Membrane; Conserved Sequence; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Ethidium; Glutamic Acid; Kanamycin Resistance; Membrane Transport Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Onium Compounds; Organophosphorus Compounds; Protein Binding; Puromycin; Substrate Specificity | 2004 |
Exploring the role of a unique carboxyl residue in EmrE by mass spectrometry.
Topics: Antiporters; Binding Sites; Biological Transport; Carbodiimides; Cyanogen Bromide; Dimerization; Escherichia coli; Escherichia coli Proteins; Glutamic Acid; Hydrogen-Ion Concentration; Mass Spectrometry; Membrane Proteins; Models, Biological; Models, Chemical; Onium Compounds; Organophosphorus Compounds; Peptides; Protein Structure, Secondary; Protein Structure, Tertiary; Protons; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2005 |
Exploring the binding domain of EmrE, the smallest multidrug transporter.
Topics: Antiporters; Binding Sites; Cell Membrane; Cysteine; Dimerization; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoresceins; Fluorescent Dyes; Glutamic Acid; Hydrogen-Ion Concentration; Indicators and Reagents; Membrane Proteins; Membrane Transport Proteins; Mesylates; Mutagenesis, Site-Directed; Onium Compounds; Organophosphorus Compounds; Plasmids; Protein Binding; Protein Structure, Tertiary; Protons; Substrate Specificity | 2005 |
The C terminus of the bacterial multidrug transporter EmrE couples drug binding to proton release.
Topics: Antiporters; Binding Sites; Escherichia coli; Escherichia coli Proteins; Glutamic Acid; Histidine; Hydrogen-Ion Concentration; Onium Compounds; Organophosphorus Compounds; Protein Binding; Protein Conformation; Protein Domains; Protons | 2018 |